DUCHENNE

Clinical trials for DUCHENNE explained in plain language.

Never miss a new study

Get alerted when new DUCHENNE trials appear

Sign up with your email to follow new studies for DUCHENNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill for duchenne MD enters Mid-Stage trial in young boys

Disease control Recruiting now

This study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …

Matched conditions: DUCHENNE

Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

DUCHENNE

Get alerted when new DUCHENNE trials appear

New pill for duchenne MD enters Mid-Stage trial in young boys